Skip to contentAccessibility settings
The science

Hormone care, with the details that matter.

Considering HRT for perimenopause or menopause? Start with a clear understanding of Estrada, the evidence and the questions to discuss with your OB/GYN.

Find your care
Hands holding a Lenova product design concept
01

What is Estrada?

Estrada is a compounded prescription vaginal cream containing estradiol and progesterone. It is intended for systemic hormone therapy, meaning effects beyond the vaginal tissue. That is a different treatment approach from low-dose local vaginal estrogen used for vaginal symptoms. A vaginal cream’s ingredients, strength and intended use matter; the route alone does not tell you its benefits or risks.

02

What does the evidence tell us?

Research on hormone therapy does not establish the safety or effectiveness of every formulation, including Estrada. Compounded drugs are not FDA-approved, and FDA does not assess their safety, effectiveness or quality before marketing. ACOG recommends FDA-approved menopausal hormone therapies over compounded options when suitable approved formulations are available. The sources below explain general evidence and limitations; they are not endorsements of Estrada.

03

What belongs in your care conversation?

Your symptoms, health history, medications and preferences help your OB/GYN assess whether HRT is appropriate. Ask about expected benefits, side effects, alternatives and follow-up. If a compounded prescription is considered, discuss why it fits your individual needs and the uncertainties involved. An assessment is a chance to understand your options; it does not guarantee a prescription or a particular result.

Further reading

FDA: Understanding the risks of compounded drugsACOG: Compounded bioidentical menopausal hormone therapyACOG: Hormone therapy for menopause

Your next step, in your own time.

Start with what brings you here.

Find your care